This inventor holds 17 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Amorepacific Corporation, Dong-A Socio Holdings Co., Ltd., Pacific Corporation. Active years: 2002-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Seoul, KR (2002 - 2017)
- Suwon-si, KR (2010 - 2021)
- Gyeonggi-do, KR (2018 - 2021)
Company Filing History:
7 out of 563 
5 out of 6 
3 out of 49 
Years Active: 2002-2025
Areas of Expertise:
Title: The Innovative Contributions of Jin Kwan Kim
Introduction: Jin Kwan Kim is a notable inventor based in Suwon-si, South Korea, who has made significant contributions in the field of therapeutic drugs. With 16 patents to his name, his work focuses primarily on developing compounds with potential medical applications.
Latest Patents: Among his latest patents, Jin Kwan Kim has developed heteroaryl compounds that serve as therapeutic drugs. This particular invention offers compounds capable of modulating the activity of Mer receptor tyrosine kinase (MERTK). It includes pharmaceutical compositions, methods for preparing these compounds, and their use as potential medicaments. The MERTK inhibitory compounds he has created display marked potency, indicating a promising future for pharmaceutical interventions in cancer treatment and other diseases linked to MERTK dysregulation.
Another significant patent includes a composition containing a bean extract aimed at improving blood circulation and vascular health. Extracted with low-concentration, low-grade alcohol, this composition demonstrates excellent effects in enhancing blood circulation, combating obesity, and preventing conditions like diabetes and hyperlipidemia. The related methods further outline approaches to improve vascular health and manage symptoms associated with these ailments.
Career Highlights: Jin Kwan Kim has further honed his expertise by working with prominent companies including Amorepacific Corporation and Dong-a Socio Holdings Co., Ltd. His experience in these firms has bolstered his research and development capabilities, driving his innovation in therapeutic compounds.
Collaborations: Throughout his career, Jin has collaborated with esteemed professionals such as Kyung Min Lim and Yeon Su Jeong. These collaborations have enriched his work, contributing to the successful development of his patented inventions.
Conclusion: Jin Kwan Kim stands out as a prolific inventor whose contributions have the potential to advance medical science and improve patient care. With a solid portfolio of patents reflecting both innovation and practical application, he continues to be a pertinent figure in the realm of therapeutic drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile